251 related articles for article (PubMed ID: 26451024)
1. Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event.
Karlinski M; Kobayashi A; Czlonkowska A; Mikulik R; Vaclavik D; Brozman M; Gdovinova Z; Švigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Bašic-Kes V; Vilionskis A; Jatuzis D; Krespi Y; Shamalov N; Andonova S; Ahmed N; Wahlgren N;
Stroke; 2015 Nov; 46(11):3184-9. PubMed ID: 26451024
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.
Dorado L; Ahmed N; Thomalla G; Lozano M; Malojcic B; Wani M; Millán M; Tomek A; Dávalos A
Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326
[TBL] [Abstract][Full Text] [Related]
3. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
4. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
5. Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
Cappellari M; Moretto G; Micheletti N; Donato F; Tomelleri G; Gulli G; Carletti M; Squintani GM; Zanoni T; Ottaviani S; Romito S; Tommasi G; Musso AM; Deotto L; Gambina G; Zimatore DS; Bovi P
J Thromb Thrombolysis; 2014 May; 37(4):549-56. PubMed ID: 23943338
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
[TBL] [Abstract][Full Text] [Related]
7. Intravenous thrombolysis for acute ischaemic stroke in patients not fully adhering to the European licence in Poland.
Karliński M; Kobayashi A; Litwin T; Sobolewski P; Fryze W; Romanowicz S; Glonek M; Nyka W; Lisewski P; Członkowska A;
Neurol Neurochir Pol; 2012; 46(1):3-14. PubMed ID: 22426757
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.
Ohta T; Okada K; Fukuda M; Masahira N; Matsuoka T; Tsuno T; Takemura M
J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402
[TBL] [Abstract][Full Text] [Related]
9. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
11. Intravenous alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe.
Karlinski M; Kobayashi A; Mikulik R; Sanak D; Wahlgren N; Czlonkowska A;
Int J Stroke; 2012 Dec; 7(8):615-22. PubMed ID: 22309238
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW).
Rha JH; Shrivastava VP; Wang Y; Lee KE; Ahmed N; Bluhmki E; Hermansson K; Wahlgren N;
Int J Stroke; 2014 Oct; 9 Suppl A100():93-101. PubMed ID: 22988894
[TBL] [Abstract][Full Text] [Related]
13. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
Campbell BCV; Ma H; Ringleb PA; Parsons MW; Churilov L; Bendszus M; Levi CR; Hsu C; Kleinig TJ; Fatar M; Leys D; Molina C; Wijeratne T; Curtze S; Dewey HM; Barber PA; Butcher KS; De Silva DA; Bladin CF; Yassi N; Pfaff JAR; Sharma G; Bivard A; Desmond PM; Schwab S; Schellinger PD; Yan B; Mitchell PJ; Serena J; Toni D; Thijs V; Hacke W; Davis SM; Donnan GA;
Lancet; 2019 Jul; 394(10193):139-147. PubMed ID: 31128925
[TBL] [Abstract][Full Text] [Related]
14. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR.
Ahmed N; Wahlgren N; Grond M; Hennerici M; Lees KR; Mikulik R; Parsons M; Roine RO; Toni D; Ringleb P;
Lancet Neurol; 2010 Sep; 9(9):866-74. PubMed ID: 20667790
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
Zhang B; Sun XJ; Ju CH
Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
[TBL] [Abstract][Full Text] [Related]
16. Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS).
Nakagawara J; Minematsu K; Okada Y; Tanahashi N; Nagahiro S; Mori E; Shinohara Y; Yamaguchi T;
Stroke; 2010 Sep; 41(9):1984-9. PubMed ID: 20651262
[TBL] [Abstract][Full Text] [Related]
17. Early Use of Statin in Patients Treated with Alteplase for Acute Ischemic Stroke.
Geng J; Song Y; Mu Z; Xu Q; Shi G; Sun Y; Chen Y; Lin Y; Pan Y; Yu L; Yang GY; Li Y
Acta Neurochir Suppl; 2016; 121():269-75. PubMed ID: 26463960
[TBL] [Abstract][Full Text] [Related]
18. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
[TBL] [Abstract][Full Text] [Related]
19. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
20. Within-day and weekly variations of thrombolysis in acute ischemic stroke: results from safe implementation of treatments in stroke-international stroke thrombolysis register.
Lorenzano S; Ahmed N; Tatlisumak T; Gomis M; Dávalos A; Mikulik R; Sevcik P; Ollikainen J; Wahlgren N; Toni D;
Stroke; 2014 Jan; 45(1):176-84. PubMed ID: 24262329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]